
|Articles|August 9, 2016
Evidera to Join PPD
PPD announces the acquisition of Evidera, an evidence-based solutions provider.
Advertisement
PPD announces the acquisition of Evidera, an evidence-based solutions provider. As a subsidiary of PPD, Evidera will be deliver peri- and post-approval studies, health economics, outcomes research, epidemiology and market access consulting.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Driven Clinical Trial Recruitment and Design
2
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
3
What Clinical Trials Can Learn from the Gig Economy About Payments
4
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
5




